Chengdu Easton Biopharmaceuticals Co., Ltd. (688513.SS)
CNY 31.24
(-0.13%)
CNY 31.24
(-0.13%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 226.57 Million CNY | -8.09% |
| 2022 | 246.52 Million CNY | 6.06% |
| 2021 | 232.42 Million CNY | 30.46% |
| 2020 | 178.16 Million CNY | 64.04% |
| 2019 | 108.61 Million CNY | -19.56% |
| 2018 | 135.02 Million CNY | 109.77% |
| 2017 | 64.36 Million CNY | 12.3% |
| 2016 | 57.31 Million CNY | 52.36% |
| 2015 | 37.61 Million CNY | 28.69% |
| 2014 | 29.23 Million CNY | 98.44% |
| 2013 | 14.73 Million CNY | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | 75.01 Million CNY | 128.28% |
| 2024 Q2 | 71.48 Million CNY | -4.7% |
| 2024 Q3 | 70.53 Million CNY | -1.33% |
| 2023 Q4 | 32.85 Million CNY | -47.17% |
| 2023 FY | 226.57 Million CNY | -8.09% |
| 2023 Q3 | 62.19 Million CNY | -11.83% |
| 2023 Q2 | 70.53 Million CNY | 15.66% |
| 2023 Q1 | 60.98 Million CNY | 19.51% |
| 2022 Q2 | 80.83 Million CNY | 50.24% |
| 2022 Q1 | 53.8 Million CNY | 16.07% |
| 2022 FY | 246.52 Million CNY | 6.06% |
| 2022 Q4 | 51.02 Million CNY | -16.15% |
| 2022 Q3 | 60.85 Million CNY | -24.71% |
| 2021 Q2 | 74.05 Million CNY | 71.05% |
| 2021 Q1 | 43.29 Million CNY | -18.78% |
| 2021 FY | 232.42 Million CNY | 30.46% |
| 2021 Q3 | 68.73 Million CNY | -7.18% |
| 2021 Q4 | 46.35 Million CNY | -32.56% |
| 2020 FY | 178.16 Million CNY | 64.04% |
| 2020 Q1 | 30.69 Million CNY | 124.34% |
| 2020 Q2 | 55.38 Million CNY | 80.43% |
| 2020 Q3 | 38.78 Million CNY | -29.97% |
| 2020 Q4 | 53.3 Million CNY | 37.43% |
| 2019 Q3 | 15.72 Million CNY | -68.7% |
| 2019 Q2 | 50.25 Million CNY | 73.65% |
| 2019 Q1 | 28.94 Million CNY | 0.0% |
| 2019 FY | 108.61 Million CNY | -19.56% |
| 2019 Q4 | 13.68 Million CNY | -13.01% |
| 2018 FY | 135.02 Million CNY | 109.77% |
| 2017 FY | 64.36 Million CNY | 12.3% |
| 2016 FY | 57.31 Million CNY | 52.36% |
| 2016 Q1 | 12.75 Million CNY | 28.05% |
| 2016 Q2 | 12.75 Million CNY | 0.0% |
| 2015 Q2 | 9.45 Million CNY | -0.0% |
| 2015 Q1 | 9.45 Million CNY | 0.0% |
| 2015 Q4 | 9.95 Million CNY | 0.0% |
| 2015 FY | 37.61 Million CNY | 28.69% |
| 2014 FY | 29.23 Million CNY | 98.44% |
| 2013 FY | 14.73 Million CNY | 0.0% |